Iannone Robert
EVP, Global Head of R&D & CMO at JAZZ
- Sold, on record
- $22M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 27, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- JAZZJazz Pharmaceuticals plcEVP, Global Head of R&D & CMO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale JAZZRoutineMar 7, 2025 2025
Sold 7,080 shares at $138.60 ($981k)
Iannone Robert, EVP, Global Head of R&D & CMO
10b5-1 planSold 7.9% of holdings ($12.3M position)82,024 shares leftFirst sale on recordFollows a Form 144Filing
- 2 Form 144 notice JAZZNoticeMar 7, 2025 same day
Filed to sell 4,017 shares ($571k)
Iannone Robert, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice JAZZNoticeMar 7, 2025 same day
Filed to sell 5,466 shares ($758k)
Iannone Robert, Officer
10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice JAZZNoticeMar 10, 2025 +3 days
Filed to sell 1,767 shares ($256k)
Iannone Robert, Officer
No 10b5-1 planFiling
- 5 Form 4 sale JAZZNo planMar 10, 2025 same day
Sold 2,403 shares at $138.41 ($333k)
Iannone Robert, EVP, Global Head of R&D & CMO
No 10b5-1 planSold 2.9% of holdings ($11.4M position)79,621 shares leftFollows a Form 144Filing
- 6 Form 144 notice JAZZNoticeNov 17, 2025 +252 days
Filed to sell 7,159 shares ($1.2M)
Iannone Robert, Officer
10b5-1 planFiling
- 7 Form 4 sale JAZZRoutineNov 17, 2025 same day
Sold 7,159 shares at $168.26 ($1.2M)
Iannone Robert, EVP, Global Head of R&D & CMO
10b5-1 planSold 9% of holdings ($13.4M position)72,628 shares leftFollows a Form 144Filing
- 8 Form 4 sale JAZZUnusualAug 27, 2026 +283 days
Sold 76,921 shares at $249.70 ($19.2M)
Iannone Robert, EVP, Global Head of R&D & CMO
10b5-1 planSold 53.9% of holdings ($35.6M position)65,686 shares left10.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Aug 31, 2026 | JAZZ | EVP, Global Head of R&D & CMO | Form 4 sale | 76,921 | $19.2M | 53.9% | Unusual | SEC |
| Nov 17, 2025 | Nov 19, 2025 | JAZZ | EVP, Global Head of R&D & CMO | Form 4 sale | 7,159 | $1.2M | 9.0% | Routine | SEC |
| Nov 17, 2025 | Nov 17, 2025 | JAZZ | Officer | Form 144 notice | 7,159 | $1.2M | Notice | SEC | |
| Mar 10, 2025 | Mar 12, 2025 | JAZZ | EVP, Global Head of R&D & CMO | Form 4 sale | 2,403 | $333k | 2.9% | No plan | SEC |
| Mar 10, 2025 | Mar 10, 2025 | JAZZ | Officer | Form 144 notice | 1,767 | $256k | Notice | SEC | |
| Mar 7, 2025 | Mar 7, 2025 | JAZZ | Officer | Form 144 notice | 5,466 | $758k | Notice | SEC | |
| Mar 7, 2025 | Mar 7, 2025 | JAZZ | Officer | Form 144 notice | 4,017 | $571k | Notice | SEC | |
| Mar 7, 2025 | Mar 7, 2025 | JAZZ | EVP, Global Head of R&D & CMO | Form 4 sale | 7,080 | $981k | 7.9% | Routine | SEC |
| Dec 9, 2022 | Dec 13, 2022 | JAZZ | EVP, Global Head of R&D | Form 4 sale | 1,844 | $279k | 4.8% | Plan not stated | SEC |